ConfRoll: all your international conferences directory and alerts at just one click

Key deadlines

Conference starts:

2012-05-14

Registration by:

2012-02-22

Early Bird Registration by:

2012-05-14

Website

Visit the conference website

Conference Description

OMICS Group invites you to attend the International Conference and Exhibition on Neurology & Therapeutics which is going to be held during May 14-16, 2012 Embassy Suites Las Vegas, USA.

OMICS Group invites you to attend the International Conference and Exhibition on Neurology & Therapeutics which is going to be held during May 14-16, 2012 Embassy Suites Las Vegas, USA. Neuro-2012 is a remarkable event which brings together a unique and International mix of large and medium pharmaceutical, biotech and diagnostic companies, leading Universities and Clinical Research Institutions making the Congress a perfect platform to share experience, foster collaborations across industry and academia and evaluate emerging technologies across the globe.
The International Conference and Exhibition on Neurology & Therapeutics will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Neurology field across the World. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies in Neurology.
Conference Highlights the following topics:
Neuroimmunology
Neuromics & Human Brain proteome
Perspectives in Neurology Research
Neurorehabilitation
Epilepsy
Current trends in Neurophysiology
Cerebral CSF Flow Studies
Diagnosis for cerebral infections
Clinical Neurophysiology & Electrophysiology

OMICS Publishing Group is an Open Access publication model that enables the dissemination of research articles to the global community. Thus, all articles published under open access can be accessed by anyone. We strongly support the Open Access initiative. Abstracts and full texts (HTML, XML and PDF format) of all articles published by OMICS Publishing Group are freely accessible to everyone immediately after publication.